Barr to Challenge Patents Protecting Prefest Hormone Therapy
Generic drugmaker Barr Laboratories said Thursday it is challenging the patents protecting King Pharmaceutical's Prefest hormone therapy....To view the full article, register now.
Already a subscriber? Click here to view full article